Most xenobiotics are metabolized and/or bioaccumulated and biomagnified in our tissues and cells, including breast tissue. Therefore, xenobiotic metabolism plays a significant role in the initiation and progression of breast cancer (BC). Existing evidence on breast cancer risk (BCR) suggests that foodborne chemical carcinogens, environmental pollution, ionizing radiation, and socioeconomic status are closely related to breast carcinogenesis. At the level of biological pathways, most xenobiotics interact with endocrine signaling, adipogenesis, angiogenesis, DNA repair, the inflammatory response, IGF-1 and NF-κB signaling, PI3K/Akt signaling, fatty acid metabolism and glycolysis, the p53 pathway, xenobiotic metabolism, and other cancer-related pathways.
Breast cancer is more prevalent in women who work night shifts, as exposure to light at night suppresses melatonin secretion and can contribute to cancer. Exposure to xenoestrogens (found in plastic packaging, pesticides, etc.), parabens (found in preservatives and cosmetics),
alkylphenols, and phytoestrogens is also harmful and can cause breast cancer. Excessive alcohol consumption, diabetes, obesity, and late menopause are also associated with breast cancer.
During puberty, a woman's breasts are vulnerable to environmental damage. Early exposure to environmental carcinogens, endocrine disruptors, and unhealthy foods (refined sugar, processed fats, food additives) promotes molecular damage that increases the risk of breast cancer.
It is increasingly recognized that environmental exposure to chemicals, such as endocrine disruptors, contributes to the development of breast cancer.
The use of cosmetics can be associated with undesirable effects due to the presence of certain chemicals. Among 50 randomly selected facial makeup products, the following substances were identified as potential carcinogens: parabens, ethoxylated compounds, formaldehyde donors, and ethanolamine and its derivatives.
Also consider the dangers of deodorants containing parabens and/or aluminum. In general, the topical application of personal care products containing estrogen-mimicking parabens poses an even greater risk, with aluminum in antiperspirants presenting an even greater risk.
Aluminum chloride, the active ingredient in antiperspirants, acts similarly to oncogenes, causing molecular transformations in cancer cells. Like parabens, aluminum salts also mimic estrogen and bioaccumulate in breast tissue, which may increase the risk of breast cancer.
Parabens are a group of endocrine-disrupting chemicals (EDCs) commonly found in personal care products, food, and pharmaceuticals. Systemic exposure to parabens has been confirmed by their widespread detection in human blood and urine samples. Although evidence from in vivo and epidemiological studies linking paraben exposure to breast cancer is limited, current evidence suggests that parabens may negatively interfere with some endocrine and intracrine targets relevant to breast carcinogenesis.
A comprehensive review addresses aspects related to the absorption and distribution of aluminum compounds, their effects on inducing oxidative stress, the estrogenic activity of aluminum, the potential disruption of hormonal pathways, and their possible role in inducing breast cancer. Available research, including epidemiological studies and clinical trials, along with previously published meta-analyses and reviews, on the relationship between aluminum-containing deodorants/antiperspirants and breast cancer risk were analyzed and discussed. Social factors, personal hygiene considerations, and lifestyle changes contribute to the increased use of antiperspirants, but do not establish a direct causal relationship with breast cancer.
The obesity epidemic is a growing concern and a major risk factor for various chronic diseases, including several types of cancer. Breast cancer (BC) is the second most common malignant tumor among women worldwide, posing a significant threat to women's health. Obesity is recognized as an independent risk factor for both the development and progression of BC. The correlation between breast cancer and obesity has been extensively studied and involves an interaction of hormonal, metabolic, and genetic factors, which are explored in this review. Inflammation and hormonal dysregulation play a significant role in promoting a pro-tumor environment through adipose tissue, which is involved in energy storage and functions as an endocrine organ. As a result, various cytokines, primarily pro-inflammatory, are released, leading to low-grade inflammation that promotes tumor growth. Furthermore, obesity also induces hormonal imbalances, particularly of estrogen and insulin, both of which drive carcinogenesis. Genetic components, such as single nucleotide polymorphisms, also play a key role in modulating the correlation between obesity and breast cancer. This review provides a comprehensive overview of the various mechanisms underlying obesity and the incidence and progression of breast cancer.
Obesity is a modifiable risk factor associated with breast cancer mortality. Obesity stimulates cancer progression through chronic low-grade inflammation in white adipose tissue, leading to the accumulation of adipose tissue macrophages. A 16-week aerobic and resistance exercise intervention attenuated adipose tissue inflammation in obese postmenopausal breast cancer survivors.
A review synthesizes the current epidemiological evidence on the differential impacts of obesity on breast cancer risk according to menopausal status. The molecular mechanisms linking obesity to breast carcinogenesis through hormonal, metabolic, inflammatory, and gut microbiota-mediated pathways were systematically examined. The present analysis reveals population-specific epidemiological variations and distinct pathophysiological mechanisms, including: i) obesity-induced hyperestrogenemia, ii) insulin resistance, iii) chronic low-grade inflammation, and iv) leptin/adiponectin dysregulation, each with menopausal status-dependent effects. For clinical practice, these findings underscore the need for risk assessment and intervention tailored to each menopausal status. In premenopausal women, particularly those with abdominal obesity, strategies may prioritize mitigating hyperinsulinemia and inflammation through a combination of physical activity and dietary modifications (e.g., reducing high-glycemic-index foods). For postmenopausal women, addressing hyperestrogenemia through weight reduction, potentially supplemented with metformin for those with insulin resistance, is of vital importance.
A meta-analysis was performed using a random effects model to investigate the association between diabetes and breast cancer risk. The risk of breast cancer in women with type 2 diabetes is increased by 27%, a figure that decreased to 16% after adjustment for BMI.
A Systematic Review and Meta-Analysis. That diabetes mellitus is associated with adverse outcomes in breast cancer throughout its full course, from initial presentation, during treatment (affecting the choice of treatment), and, ultimately, to mortality. Diabetes therefore deserves additional attention to assess possible causal relationships that potentially could be modified to improve outcomes.
Metabolic alterations locally affect mammary adipose tissue (AT) and interfere with the molecular mechanisms of bidirectional communication between fat and cancer cells, which could contribute to worsening the cancer phenotype. Some factors released from AT contribute to AT remodeling, adipogenesis, innervation, and angiogenesis by acting in autocrine and paracrine ways. Other AT factors act endocrinely and influence the functions of many tissues, thus controlling appetite, food intake, glucose elimination, and energy expenditure. More than 350 proteins have been identified in mammary AT using proteomic approaches. These factors are called "adipokines" and include leptin, adiponectin, resistin, growth factors (IGF1, insulin-like growth factor 1; VEGF, vascular endothelial growth factor; EGF, epidermal growth factor; FGF, fibroblast growth factor; HGF, hepatocyte growth factor; NGF, nerve growth factor; TGFβ, transforming growth factor), enzymes (autotaxin), and cytokines (interleukin [IL]-1, IL-6, IL-8, CCL5, tumor necrosis factor-TNF-α).
The association between insulin resistance (IR), type 2 diabetes mellitus (T2DM), and cancer is increasingly recognized and represents a growing challenge to global health, given the increase The incidence of these conditions is constantly increasing. Studies indicate that people with type 2 diabetes have a 10% to 20% increased risk of developing various solid tumors, including colorectal, breast, pancreatic, and liver cancers. The relative risk (RR) varies depending on the type of cancer: pancreatic and liver cancers show a particularly strong association (RR 2.0–2.5), while colorectal and breast cancers show a moderate increase (RR 1.2–1.5). Insulin resistance contributes to hyperglycemia, chronic inflammation, and altered lipid metabolism. Together, these factors create a pro-tumor environment conducive to cancer development and progression. In individuals with insulin resistance (IR), hyperinsulinemia activates the insulin-like growth factor 1 (IGF1R) signaling pathway, which in turn activates cancer-associated pathways, such as mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PIK3CA), that promote cell proliferation and survival, thus favoring tumor growth. Both IR and type 2 diabetes mellitus (T2DM) are associated with increased morbidity and mortality in cancer patients.
This meta-analysis offers a comprehensive view of the various clinical, sociodemographic, and lifestyle factors that influence breast cancer mortality. The findings highlight the disproportionate burden of mortality in low- and middle-income countries, particularly in Africa, where access to early detection, quality treatment, and follow-up care remains limited. https://link.springer.com/article/10.1007/s11010-025-05245-8 (2025)--------------------------------------------
Major modifiable risk factors, such as obesity, smoking, diabetes, and HIV seropositivity, were consistently associated with increased mortality, reinforcing the importance of integrated noncommunicable disease (NCD) prevention within national cancer control programs. Furthermore, effective therapeutic interventions and hormone therapy were associated with significantly improved survival, underscoring the crucial need to expand access to these treatments through universal health coverage, public procurement, and capacity building for healthcare personnel.
In addition, the high mortality observed in patients with luminal B subtypes, high allostatic burden, and advanced age underscores the importance of molecular subtyping, psychosocial assessment, and early intervention. These findings advocate for personalized care models that incorporate not only biological risk factors but also social determinants of health.
In my third article Fenugreek and Okra are found to remove microplastics from the water. Just wondering if such use of either may remove those same microplastics from our Gut? Maybe there is current research testing for such, if not. future research would answer the question.
Good suggestion, Just; your intuition is invaluable. It seems that it's possible to eliminate microplastics from water and the gut, according to Gemini's response. A study published by the American Chemical Society (ACS) in its journal ACS Omega, led by Dr. Rajani Srinivasan of Tarleton State University (Texas), demonstrated that extracts of okra (Abelmoschus esculentus) and fenugreek (Trigonella foenum-graecum) can attract, bind, and eliminate up to 90% of microplastics in various types of water.
The secret behind this ability isn't magic, but purely biochemical: it's based on their polysaccharides (long-chain carbohydrates) and their mucilaginous properties (that viscous or sticky texture so characteristic of both plants). The Biochemical Mechanism: Bridging Flocculation
In conventional wastewater treatment, synthetic flocculants (such as polyacrylamide) are used to clump together floating solid waste and cause it to sink. However, these synthetic chemicals are toxic to ecosystems and can leave hazardous residues.
1) The natural polysaccharides of okra and fenugreek act as an environmentally friendly and biodegradable substitute through two steps:
2) Charge Neutralization: The plant compounds interact with the surface charges of microplastics, reducing the natural repulsion between the plastic particles.
3) Bridging Flocculation: The incredibly long chains of complex carbohydrates in these plants act like "adhesive nets." They capture dispersed microplastics (particles smaller than 5 millimeters), binding them together to form larger clumps or aggregates (flocs) that increase in weight and settle to the bottom of the container, drastically facilitating their physical filtration.
If these polysaccharides are able to trap microplastics so efficiently in external water, could they replicate that same "molecular net" mechanism within the human gastrointestinal tract to prevent their absorption?
Although there are no human clinical trials that have precisely measured the percentage of microplastics eliminated in the gut by these plants, digestive biochemistry and fluid physics strongly support the idea that the mechanism is perfectly viable in the intestinal lumen.
The behavior of these compounds in the digestive system is based on the following principles:
Mechanism of Action in the Intestinal Lumen
When we ingest okra mucilage or fenugreek polysaccharides (especially its soluble fiber rich in galactomannans), they are not digested in the stomach or small intestine, as we lack the necessary enzymes to break their bonds.
1) Instead, they undergo a deep hydration process:
2) Formation of a Viscous Hydrogel: When mixed with chyme (the mass of semi-digested food), the polysaccharides form a high-viscosity, three-dimensional gel matrix.
3) Physical Trapping (Adsorption and Flocculation): Similar to water tanks, microplastic and nanoplastic particles ingested with food or drink are physically trapped within this plant-based gelatin mesh. The hydrophobic forces of the plastic cause it to preferentially interact with the organic fiber matrix rather than with the aqueous intestinal environment.
4) Epithelial Barrier Blockage: When agglomerated into larger flocs and surrounded by a protective gel layer, microplastics lose the ability to come into direct contact with enterocytes (the cells of the intestinal wall) or to cross tight junctions via paracellularity, preventing their translocation into the bloodstream or lymphatic system.
5) Mechanical Excretion: The gel mass travels intact along the intestine to the colon, carrying the trapped plastics with it for direct elimination in the feces.
CRITICAL FACTORS AND BEHAVIOR BY SECTION
The transit of these polysaccharides varies drastically along the digestive tract, affecting their interaction with xenobiotics (compounds foreign to the body):
1) Stomach and Small Intestine: This is where the hydrogel is most stable and exerts its maximum sequestering capacity. By maintaining high viscosity, it reduces the diffusion of tiny particles into the microvilli.
2) Colon (Large Intestine): Upon reaching the colon, the gut microbiota begins to ferment these polysaccharides. The galactomannans in fenugreek and the pectins in okra are excellent prebiotics that the bacteria transform into short-chain fatty acids (SCFAs).
The Biochemical Nuance: As the microbiota breaks down the gel structure in the colon to feed, the trapped microplastics are released from the "network." However, at this point, the risk of systemic absorption is exponentially lower than in the small intestine, since the colonic mucosa is primarily designed to absorb water and electrolytes, not nutrients or macromolecules. The remaining microplastics are simply expelled.
An Additional Benefit for the Intestinal Barrier
In addition to physical trapping, both plant extracts offer crucial indirect protection: they reinforce mucosal integrity.
Microplastics and nanoplastics are known to induce local oxidative stress and disruption of tight junction proteins, leading to intestinal hyperpermeability. By coating the mucosa with a demulcent (protective) layer, okra and fenugreek mitigate the mechanical and chemical inflammation caused by these insoluble particles, helping to maintain the intestine's natural barrier function in optimal condition.
1. The Structure of Galactomannans (Fenugreek) vs. Other Fibers: Galactomannans are linear polymers formed by a backbone of D-mannose units linked by β-(1→4) bonds, to which individual D-galactose units are attached via α-(1→6) bonds.
The "Umbrella Effect" of Fenugreek: Due to the 1:1 ratio, almost every mannose molecule has a galactose molecule attached. This density of side branching generates strong steric hindrance: the polymer chains cannot align or crystallize with each other, maximizing interactions with the surrounding water. The result is a hydrogel with exceptionally high pseudoplastic viscosity at very low concentrations, ideal for creating the "adhesive network" that traps plastic microparticles.
2. Okra Mucilage: Polyelectrolytic Complexity
Unlike fenugreek, okra mucilage is not a pure galactomannan, but a complex mixture of agglutinated polysaccharides, composed mainly of rhamnogalacturonans (a type of acid pectin) and long chains of galactose and uronic acids.
• Anionic Character: The presence of galacturonic acid gives it free negative charges along its polymeric structure.
• Trapping Mechanism: While fenugreek galactomannans trap microplastics primarily through mechanical confinement (physical network) and hydrophobic forces, okra adds an electrostatic trapping component. It can interact with the polar surface charges of certain fragmented microplastics (which often acquire charges through environmental oxidation) or with dietary cations (such as calcium, Ca²⁺) to form cross-links that harden the gel during intestinal transit.
3. Comparison with Other Common Soluble Fibers
To understand why fenugreek and okra are biochemically superior for sequestering insoluble xenobiotics like microplastics, we can compare them with conventional dietary soluble fibers: Inulin and Fructooligosaccharides (FOS)
• Structure: Very short-chain fructose polymers (low degree of polymerization).
• Behavior: They are highly soluble but do not form viscous gels. They pass through the small intestine in a liquid and fluid form, offering virtually no surface area for mechanical entrapment. They are excellent prebiotics, but ineffective for the flocculation of macromolecules.
Beta-glucans (Oats and Barley)
• Structure: Linear, single-chain glucose polymers with mixed β-(1→3) and β-(1→4) linkages.
• Behavior: They form viscous solutions that reduce the absorption of cholesterol and glucose by interfering with lipid micelles. However, their linear structure and lack of dense side branches limit their ability to form three-dimensional networks capable of retaining solid microplastic particles with the same degree of hydrophobic tenacity as 1:1 galactomannans.
Right back at you Gui, however I find your ability to find useful information trumps my curiosity and intuition. Just Sayn't
Cool beans...not wrote in stone but leans heavy towards good things to use. If the memory is working, Apple Pectin may have been advised for the same or maybe similar. Not clear on the Apple Pectin though. What is bubbling up from the memory is possibly it was recommended for mopping up Lead, heavy metals?
You, Just, have a very accurate view. It seems that DMSO has broadened its scope. The relationship between apple pectin and the reduction of microplastics in the body is an emerging and very promising field of research. Although pectin has traditionally been studied and used clinically for its ability to chelate heavy metals, current scientific evidence (data from 2024-2026) is beginning to validate its specific use in mitigating the impact of microplastics trapped in the gastrointestinal tract. The biochemical mechanism by which it acts and the relevant scientific references are detailed below. Mechanisms of Action in the Digestive System: Apple pectin is a structural polysaccharide rich in D-galacturonic acid. Its effectiveness against ingested microplastics is based on three pillars: Trapping in the gel matrix (Viscosity): Upon reaching the stomach and small intestine, the highly esterified pectin forms a three-dimensional hydrogel with high viscosity. This gel physically envelops the microplastic particles suspended in the chyme, limiting their direct contact with the intestinal epithelium and accelerating their passage towards excretion. Surface adsorption:
Suspended microplastics often acquire surface charges or carry hydrophobic contaminants and additives. The hydroxyl and carboxyl groups of pectin facilitate binding interactions that help "fix" these particles within the soluble fiber matrix. Acceleration of transit and fecal volume: Since it is not digestible in the small intestine, pectin increases fecal bulk and stimulates peristalsis, which drastically reduces the intestinal retention time of invasive plastics, decreasing the likelihood of smaller particles (nanoplastics) undergoing systemic translocation. Scientific Evidence and Links: At the industrial and environmental levels, pectin matrices are already commonly used to capture effluents and pollutants due to their porosity
In the field of human health and in vivo models, the most recent research focuses on the use of fibers and binders to force the fecal excretion of plastics: Fecal excretion of microplastics using binders: Recent studies on intestinal transit dynamics confirm that The use of soluble fiber matrices (such as the combination of apple pectin and chitosan) generates a significant and measurable increase in the amount of plastic particles expelled through feces, reducing their accumulation in host tissues
Mitigation of plastic-bound toxicity: Microplastics frequently act as carriers of heavy metals (lead, cadmium) and chemical compounds in the gut (Microplastics as vectors of heavy metals and PFAS - PubMed). This is where pectin offers a dual benefit: while it binds to the plastic, its well-known chelating capacity captures the heavy metals released by these particles in the digestive tract, an effect demonstrated in clinical trials where it increases urinary excretion of arsenic, cadmium, and lead without altering essential minerals (The effect of modified citrus pectin on urinary excretion of toxic elements - PubMed). Microbiota protection: Microplastics cause mucosal inflammation and dysbiosis. Fermentation of pectin by colonic bacteria produces short-chain fatty acids (such as butyrate), reinforcing the epithelial barrier against nanoparticle penetration (Exploring the Prebiotic Potentials of Hydrolyzed Pectins - MDPI Note: Generic MDPI link for general reference). In short: Apple pectin doesn't "dissolve" plastic, but rather acts as a shield and carrier. By forming a dense gel in the gut, it encapsulates plastic particles and their associated toxins, blocking their absorption and forcing their safe elimination through feces.
Most xenobiotics are metabolized and/or bioaccumulated and biomagnified in our tissues and cells, including breast tissue. Therefore, xenobiotic metabolism plays a significant role in the initiation and progression of breast cancer (BC). Existing evidence on breast cancer risk (BCR) suggests that foodborne chemical carcinogens, environmental pollution, ionizing radiation, and socioeconomic status are closely related to breast carcinogenesis. At the level of biological pathways, most xenobiotics interact with endocrine signaling, adipogenesis, angiogenesis, DNA repair, the inflammatory response, IGF-1 and NF-κB signaling, PI3K/Akt signaling, fatty acid metabolism and glycolysis, the p53 pathway, xenobiotic metabolism, and other cancer-related pathways.
Breast cancer is more prevalent in women who work night shifts, as exposure to light at night suppresses melatonin secretion and can contribute to cancer. Exposure to xenoestrogens (found in plastic packaging, pesticides, etc.), parabens (found in preservatives and cosmetics),
alkylphenols, and phytoestrogens is also harmful and can cause breast cancer. Excessive alcohol consumption, diabetes, obesity, and late menopause are also associated with breast cancer.
During puberty, a woman's breasts are vulnerable to environmental damage. Early exposure to environmental carcinogens, endocrine disruptors, and unhealthy foods (refined sugar, processed fats, food additives) promotes molecular damage that increases the risk of breast cancer.
It is increasingly recognized that environmental exposure to chemicals, such as endocrine disruptors, contributes to the development of breast cancer.
The use of cosmetics can be associated with undesirable effects due to the presence of certain chemicals. Among 50 randomly selected facial makeup products, the following substances were identified as potential carcinogens: parabens, ethoxylated compounds, formaldehyde donors, and ethanolamine and its derivatives.
Also consider the dangers of deodorants containing parabens and/or aluminum. In general, the topical application of personal care products containing estrogen-mimicking parabens poses an even greater risk, with aluminum in antiperspirants presenting an even greater risk.
Aluminum chloride, the active ingredient in antiperspirants, acts similarly to oncogenes, causing molecular transformations in cancer cells. Like parabens, aluminum salts also mimic estrogen and bioaccumulate in breast tissue, which may increase the risk of breast cancer.
Parabens are a group of endocrine-disrupting chemicals (EDCs) commonly found in personal care products, food, and pharmaceuticals. Systemic exposure to parabens has been confirmed by their widespread detection in human blood and urine samples. Although evidence from in vivo and epidemiological studies linking paraben exposure to breast cancer is limited, current evidence suggests that parabens may negatively interfere with some endocrine and intracrine targets relevant to breast carcinogenesis.
A comprehensive review addresses aspects related to the absorption and distribution of aluminum compounds, their effects on inducing oxidative stress, the estrogenic activity of aluminum, the potential disruption of hormonal pathways, and their possible role in inducing breast cancer. Available research, including epidemiological studies and clinical trials, along with previously published meta-analyses and reviews, on the relationship between aluminum-containing deodorants/antiperspirants and breast cancer risk were analyzed and discussed. Social factors, personal hygiene considerations, and lifestyle changes contribute to the increased use of antiperspirants, but do not establish a direct causal relationship with breast cancer.
https://www.mdpi.com/1660-4601/19/3/1873 (2022).--
https://medcraveonline.com/JCPCR/JCPCR-13-00492.pdf (2022).--
https://www.mdpi.com/1660-4601/17/2/493 (2020).--
https://www.sciencedirect.com/science/article/abs/pii/B9780323996846000112 (2023).-
https://www.mdpi.com/1660-4601/20/6/4780 (2023).--
- https://www.mdpi.com/2075-1729/14/3/402 (2024).--
https://link.springer.com/article/10.1186/s12905-025-04051-0 (2025)
https://scholar.google.com/scholar?as_ylo=2025&q=Deodorant+cosmetics+and+breast+cancer&hl=es&as_sdt=0,5 (2025)
https://onlinelibrary.wiley.com/doi/full/10.1155/joch/5590021(202)
https://onlinelibrary.wiley.com/doi/full/10.1111/jocd.70639 (2026)
--------------------------
The obesity epidemic is a growing concern and a major risk factor for various chronic diseases, including several types of cancer. Breast cancer (BC) is the second most common malignant tumor among women worldwide, posing a significant threat to women's health. Obesity is recognized as an independent risk factor for both the development and progression of BC. The correlation between breast cancer and obesity has been extensively studied and involves an interaction of hormonal, metabolic, and genetic factors, which are explored in this review. Inflammation and hormonal dysregulation play a significant role in promoting a pro-tumor environment through adipose tissue, which is involved in energy storage and functions as an endocrine organ. As a result, various cytokines, primarily pro-inflammatory, are released, leading to low-grade inflammation that promotes tumor growth. Furthermore, obesity also induces hormonal imbalances, particularly of estrogen and insulin, both of which drive carcinogenesis. Genetic components, such as single nucleotide polymorphisms, also play a key role in modulating the correlation between obesity and breast cancer. This review provides a comprehensive overview of the various mechanisms underlying obesity and the incidence and progression of breast cancer.
Obesity is a modifiable risk factor associated with breast cancer mortality. Obesity stimulates cancer progression through chronic low-grade inflammation in white adipose tissue, leading to the accumulation of adipose tissue macrophages. A 16-week aerobic and resistance exercise intervention attenuated adipose tissue inflammation in obese postmenopausal breast cancer survivors.
A review synthesizes the current epidemiological evidence on the differential impacts of obesity on breast cancer risk according to menopausal status. The molecular mechanisms linking obesity to breast carcinogenesis through hormonal, metabolic, inflammatory, and gut microbiota-mediated pathways were systematically examined. The present analysis reveals population-specific epidemiological variations and distinct pathophysiological mechanisms, including: i) obesity-induced hyperestrogenemia, ii) insulin resistance, iii) chronic low-grade inflammation, and iv) leptin/adiponectin dysregulation, each with menopausal status-dependent effects. For clinical practice, these findings underscore the need for risk assessment and intervention tailored to each menopausal status. In premenopausal women, particularly those with abdominal obesity, strategies may prioritize mitigating hyperinsulinemia and inflammation through a combination of physical activity and dietary modifications (e.g., reducing high-glycemic-index foods). For postmenopausal women, addressing hyperestrogenemia through weight reduction, potentially supplemented with metformin for those with insulin resistance, is of vital importance.
https://link.springer.com/article/10.1007/s10549-017-4576-y (2018)
https://www.tandfonline.com/doi/full/10.1080/15384047.2025.2501345#abstract (2025)
https://www.spandidos-publications.com/10.3892/mco.2026.2932# (2026)
A meta-analysis was performed using a random effects model to investigate the association between diabetes and breast cancer risk. The risk of breast cancer in women with type 2 diabetes is increased by 27%, a figure that decreased to 16% after adjustment for BMI.
https://www.nature.com/articles/bjc2012414/ (2012)
A Systematic Review and Meta-Analysis. That diabetes mellitus is associated with adverse outcomes in breast cancer throughout its full course, from initial presentation, during treatment (affecting the choice of treatment), and, ultimately, to mortality. Diabetes therefore deserves additional attention to assess possible causal relationships that potentially could be modified to improve outcomes.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055858/ (2011)-------------------------------------
Metabolic alterations locally affect mammary adipose tissue (AT) and interfere with the molecular mechanisms of bidirectional communication between fat and cancer cells, which could contribute to worsening the cancer phenotype. Some factors released from AT contribute to AT remodeling, adipogenesis, innervation, and angiogenesis by acting in autocrine and paracrine ways. Other AT factors act endocrinely and influence the functions of many tissues, thus controlling appetite, food intake, glucose elimination, and energy expenditure. More than 350 proteins have been identified in mammary AT using proteomic approaches. These factors are called "adipokines" and include leptin, adiponectin, resistin, growth factors (IGF1, insulin-like growth factor 1; VEGF, vascular endothelial growth factor; EGF, epidermal growth factor; FGF, fibroblast growth factor; HGF, hepatocyte growth factor; NGF, nerve growth factor; TGFβ, transforming growth factor), enzymes (autotaxin), and cytokines (interleukin [IL]-1, IL-6, IL-8, CCL5, tumor necrosis factor-TNF-α).
https://www.frontiersin.org/articles/10.3389/fonc.2020.01554/full (2022)------------------------------------
The association between insulin resistance (IR), type 2 diabetes mellitus (T2DM), and cancer is increasingly recognized and represents a growing challenge to global health, given the increase The incidence of these conditions is constantly increasing. Studies indicate that people with type 2 diabetes have a 10% to 20% increased risk of developing various solid tumors, including colorectal, breast, pancreatic, and liver cancers. The relative risk (RR) varies depending on the type of cancer: pancreatic and liver cancers show a particularly strong association (RR 2.0–2.5), while colorectal and breast cancers show a moderate increase (RR 1.2–1.5). Insulin resistance contributes to hyperglycemia, chronic inflammation, and altered lipid metabolism. Together, these factors create a pro-tumor environment conducive to cancer development and progression. In individuals with insulin resistance (IR), hyperinsulinemia activates the insulin-like growth factor 1 (IGF1R) signaling pathway, which in turn activates cancer-associated pathways, such as mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PIK3CA), that promote cell proliferation and survival, thus favoring tumor growth. Both IR and type 2 diabetes mellitus (T2DM) are associated with increased morbidity and mortality in cancer patients.
This meta-analysis offers a comprehensive view of the various clinical, sociodemographic, and lifestyle factors that influence breast cancer mortality. The findings highlight the disproportionate burden of mortality in low- and middle-income countries, particularly in Africa, where access to early detection, quality treatment, and follow-up care remains limited. https://link.springer.com/article/10.1007/s11010-025-05245-8 (2025)--------------------------------------------
Major modifiable risk factors, such as obesity, smoking, diabetes, and HIV seropositivity, were consistently associated with increased mortality, reinforcing the importance of integrated noncommunicable disease (NCD) prevention within national cancer control programs. Furthermore, effective therapeutic interventions and hormone therapy were associated with significantly improved survival, underscoring the crucial need to expand access to these treatments through universal health coverage, public procurement, and capacity building for healthcare personnel.
In addition, the high mortality observed in patients with luminal B subtypes, high allostatic burden, and advanced age underscores the importance of molecular subtyping, psychosocial assessment, and early intervention. These findings advocate for personalized care models that incorporate not only biological risk factors but also social determinants of health.
https://link.springer.com/article/10.1186/s12889-025-24036-w (2026)
In my third article Fenugreek and Okra are found to remove microplastics from the water. Just wondering if such use of either may remove those same microplastics from our Gut? Maybe there is current research testing for such, if not. future research would answer the question.
Good suggestion, Just; your intuition is invaluable. It seems that it's possible to eliminate microplastics from water and the gut, according to Gemini's response. A study published by the American Chemical Society (ACS) in its journal ACS Omega, led by Dr. Rajani Srinivasan of Tarleton State University (Texas), demonstrated that extracts of okra (Abelmoschus esculentus) and fenugreek (Trigonella foenum-graecum) can attract, bind, and eliminate up to 90% of microplastics in various types of water.
The secret behind this ability isn't magic, but purely biochemical: it's based on their polysaccharides (long-chain carbohydrates) and their mucilaginous properties (that viscous or sticky texture so characteristic of both plants). The Biochemical Mechanism: Bridging Flocculation
In conventional wastewater treatment, synthetic flocculants (such as polyacrylamide) are used to clump together floating solid waste and cause it to sink. However, these synthetic chemicals are toxic to ecosystems and can leave hazardous residues.
1) The natural polysaccharides of okra and fenugreek act as an environmentally friendly and biodegradable substitute through two steps:
2) Charge Neutralization: The plant compounds interact with the surface charges of microplastics, reducing the natural repulsion between the plastic particles.
3) Bridging Flocculation: The incredibly long chains of complex carbohydrates in these plants act like "adhesive nets." They capture dispersed microplastics (particles smaller than 5 millimeters), binding them together to form larger clumps or aggregates (flocs) that increase in weight and settle to the bottom of the container, drastically facilitating their physical filtration.
If these polysaccharides are able to trap microplastics so efficiently in external water, could they replicate that same "molecular net" mechanism within the human gastrointestinal tract to prevent their absorption?
Although there are no human clinical trials that have precisely measured the percentage of microplastics eliminated in the gut by these plants, digestive biochemistry and fluid physics strongly support the idea that the mechanism is perfectly viable in the intestinal lumen.
The behavior of these compounds in the digestive system is based on the following principles:
Mechanism of Action in the Intestinal Lumen
When we ingest okra mucilage or fenugreek polysaccharides (especially its soluble fiber rich in galactomannans), they are not digested in the stomach or small intestine, as we lack the necessary enzymes to break their bonds.
1) Instead, they undergo a deep hydration process:
2) Formation of a Viscous Hydrogel: When mixed with chyme (the mass of semi-digested food), the polysaccharides form a high-viscosity, three-dimensional gel matrix.
3) Physical Trapping (Adsorption and Flocculation): Similar to water tanks, microplastic and nanoplastic particles ingested with food or drink are physically trapped within this plant-based gelatin mesh. The hydrophobic forces of the plastic cause it to preferentially interact with the organic fiber matrix rather than with the aqueous intestinal environment.
4) Epithelial Barrier Blockage: When agglomerated into larger flocs and surrounded by a protective gel layer, microplastics lose the ability to come into direct contact with enterocytes (the cells of the intestinal wall) or to cross tight junctions via paracellularity, preventing their translocation into the bloodstream or lymphatic system.
5) Mechanical Excretion: The gel mass travels intact along the intestine to the colon, carrying the trapped plastics with it for direct elimination in the feces.
CRITICAL FACTORS AND BEHAVIOR BY SECTION
The transit of these polysaccharides varies drastically along the digestive tract, affecting their interaction with xenobiotics (compounds foreign to the body):
1) Stomach and Small Intestine: This is where the hydrogel is most stable and exerts its maximum sequestering capacity. By maintaining high viscosity, it reduces the diffusion of tiny particles into the microvilli.
2) Colon (Large Intestine): Upon reaching the colon, the gut microbiota begins to ferment these polysaccharides. The galactomannans in fenugreek and the pectins in okra are excellent prebiotics that the bacteria transform into short-chain fatty acids (SCFAs).
The Biochemical Nuance: As the microbiota breaks down the gel structure in the colon to feed, the trapped microplastics are released from the "network." However, at this point, the risk of systemic absorption is exponentially lower than in the small intestine, since the colonic mucosa is primarily designed to absorb water and electrolytes, not nutrients or macromolecules. The remaining microplastics are simply expelled.
An Additional Benefit for the Intestinal Barrier
In addition to physical trapping, both plant extracts offer crucial indirect protection: they reinforce mucosal integrity.
Microplastics and nanoplastics are known to induce local oxidative stress and disruption of tight junction proteins, leading to intestinal hyperpermeability. By coating the mucosa with a demulcent (protective) layer, okra and fenugreek mitigate the mechanical and chemical inflammation caused by these insoluble particles, helping to maintain the intestine's natural barrier function in optimal condition.
1. The Structure of Galactomannans (Fenugreek) vs. Other Fibers: Galactomannans are linear polymers formed by a backbone of D-mannose units linked by β-(1→4) bonds, to which individual D-galactose units are attached via α-(1→6) bonds.
The "Umbrella Effect" of Fenugreek: Due to the 1:1 ratio, almost every mannose molecule has a galactose molecule attached. This density of side branching generates strong steric hindrance: the polymer chains cannot align or crystallize with each other, maximizing interactions with the surrounding water. The result is a hydrogel with exceptionally high pseudoplastic viscosity at very low concentrations, ideal for creating the "adhesive network" that traps plastic microparticles.
2. Okra Mucilage: Polyelectrolytic Complexity
Unlike fenugreek, okra mucilage is not a pure galactomannan, but a complex mixture of agglutinated polysaccharides, composed mainly of rhamnogalacturonans (a type of acid pectin) and long chains of galactose and uronic acids.
• Anionic Character: The presence of galacturonic acid gives it free negative charges along its polymeric structure.
• Trapping Mechanism: While fenugreek galactomannans trap microplastics primarily through mechanical confinement (physical network) and hydrophobic forces, okra adds an electrostatic trapping component. It can interact with the polar surface charges of certain fragmented microplastics (which often acquire charges through environmental oxidation) or with dietary cations (such as calcium, Ca²⁺) to form cross-links that harden the gel during intestinal transit.
3. Comparison with Other Common Soluble Fibers
To understand why fenugreek and okra are biochemically superior for sequestering insoluble xenobiotics like microplastics, we can compare them with conventional dietary soluble fibers: Inulin and Fructooligosaccharides (FOS)
• Structure: Very short-chain fructose polymers (low degree of polymerization).
• Behavior: They are highly soluble but do not form viscous gels. They pass through the small intestine in a liquid and fluid form, offering virtually no surface area for mechanical entrapment. They are excellent prebiotics, but ineffective for the flocculation of macromolecules.
Beta-glucans (Oats and Barley)
• Structure: Linear, single-chain glucose polymers with mixed β-(1→3) and β-(1→4) linkages.
• Behavior: They form viscous solutions that reduce the absorption of cholesterol and glucose by interfering with lipid micelles. However, their linear structure and lack of dense side branches limit their ability to form three-dimensional networks capable of retaining solid microplastic particles with the same degree of hydrophobic tenacity as 1:1 galactomannans.
https://pubmed.ncbi.nlm.nih.gov/35474815/
https://www.redalyc.org/journal/470/47058475012/47058475012.pdf
https://pubmed.ncbi.nlm.nih.gov/28266744/
Right back at you Gui, however I find your ability to find useful information trumps my curiosity and intuition. Just Sayn't
Cool beans...not wrote in stone but leans heavy towards good things to use. If the memory is working, Apple Pectin may have been advised for the same or maybe similar. Not clear on the Apple Pectin though. What is bubbling up from the memory is possibly it was recommended for mopping up Lead, heavy metals?
You, Just, have a very accurate view. It seems that DMSO has broadened its scope. The relationship between apple pectin and the reduction of microplastics in the body is an emerging and very promising field of research. Although pectin has traditionally been studied and used clinically for its ability to chelate heavy metals, current scientific evidence (data from 2024-2026) is beginning to validate its specific use in mitigating the impact of microplastics trapped in the gastrointestinal tract. The biochemical mechanism by which it acts and the relevant scientific references are detailed below. Mechanisms of Action in the Digestive System: Apple pectin is a structural polysaccharide rich in D-galacturonic acid. Its effectiveness against ingested microplastics is based on three pillars: Trapping in the gel matrix (Viscosity): Upon reaching the stomach and small intestine, the highly esterified pectin forms a three-dimensional hydrogel with high viscosity. This gel physically envelops the microplastic particles suspended in the chyme, limiting their direct contact with the intestinal epithelium and accelerating their passage towards excretion. Surface adsorption:
Suspended microplastics often acquire surface charges or carry hydrophobic contaminants and additives. The hydroxyl and carboxyl groups of pectin facilitate binding interactions that help "fix" these particles within the soluble fiber matrix. Acceleration of transit and fecal volume: Since it is not digestible in the small intestine, pectin increases fecal bulk and stimulates peristalsis, which drastically reduces the intestinal retention time of invasive plastics, decreasing the likelihood of smaller particles (nanoplastics) undergoing systemic translocation. Scientific Evidence and Links: At the industrial and environmental levels, pectin matrices are already commonly used to capture effluents and pollutants due to their porosity
In the field of human health and in vivo models, the most recent research focuses on the use of fibers and binders to force the fecal excretion of plastics: Fecal excretion of microplastics using binders: Recent studies on intestinal transit dynamics confirm that The use of soluble fiber matrices (such as the combination of apple pectin and chitosan) generates a significant and measurable increase in the amount of plastic particles expelled through feces, reducing their accumulation in host tissues
Mitigation of plastic-bound toxicity: Microplastics frequently act as carriers of heavy metals (lead, cadmium) and chemical compounds in the gut (Microplastics as vectors of heavy metals and PFAS - PubMed). This is where pectin offers a dual benefit: while it binds to the plastic, its well-known chelating capacity captures the heavy metals released by these particles in the digestive tract, an effect demonstrated in clinical trials where it increases urinary excretion of arsenic, cadmium, and lead without altering essential minerals (The effect of modified citrus pectin on urinary excretion of toxic elements - PubMed). Microbiota protection: Microplastics cause mucosal inflammation and dysbiosis. Fermentation of pectin by colonic bacteria produces short-chain fatty acids (such as butyrate), reinforcing the epithelial barrier against nanoparticle penetration (Exploring the Prebiotic Potentials of Hydrolyzed Pectins - MDPI Note: Generic MDPI link for general reference). In short: Apple pectin doesn't "dissolve" plastic, but rather acts as a shield and carrier. By forming a dense gel in the gut, it encapsulates plastic particles and their associated toxins, blocking their absorption and forcing their safe elimination through feces.
https://www.newswire.com/news/sifts-microplastic-binding-supplement-review-2026-chitosan-microplastic-research (2026)
https://pmc.ncbi.nlm.nih.gov/articles/PMC9173971/ (2022)
https://www.newswire.com/news/sifts-microplastic-binding-supplement-review-2026-chitosan-microplastic-research#:~:text=Apple%20pectin%20forms%20a%20gel%20matrix%20in,and%20water%2Dbinding%20properties%20in%20the%20intestinal%20environment.
(2025)